Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent

被引:76
作者
Liu, Lihong [2 ]
Huang, Yuan [1 ]
Riduan, Siti Nurhanna [2 ]
Gao, Shujun [2 ]
Yang, Yiyan [2 ]
Fan, Weimin [1 ,3 ]
Zhang, Yugen [2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
[2] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore
[3] Med Univ S Carolina, Charleston, SC 29425 USA
基金
中国国家自然科学基金;
关键词
Main-chain imidazolium oligomer; Broad spectrum antimicrobial agent; Drug-resistant microbials; Haemoconipatible; High in vivo efficacy; HOST-DEFENSE PEPTIDES; DE-NOVO DESIGN; IONIC LIQUIDS; POLYMERS; ANTIBACTERIAL; SALTS; DERIVATIVES; MEMBRANES; BACTERIA; IMMUNITY;
D O I
10.1016/j.biomaterials.2012.08.006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Human health has been challenged by multi-drug-resistant microorganisms for several decades. Herein, we have developed a main-chain imidazolium oligomer (IBN-1) material to combat broad spectrum of pathogenic strains, including drug-resistant Klebsiella pneumoniae, Vancomycin-resistant enterococcus, Methicillin-resistant Staphylococcus aureus and fluconazole-resistant yeast Cryptococcus neoformans, while displaying minimal hemolysis (HC50/MIC values over 3000) and a very high therapeutic index of 37 for killing S. aureus under inflammatory conditions in vivo. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8625 / 8631
页数:7
相关论文
共 50 条
[1]   Investigating the Effect of Increasing Charge Density on the Hemolytic Activity of Synthetic Antimicrobial Polymers [J].
Al-Badri, Zoha M. ;
Som, Abhigyan ;
Lyon, Sarah ;
Nelson, Christopher F. ;
Nusslein, Klaus ;
Tew, Gregory N. .
BIOMACROMOLECULES, 2008, 9 (10) :2805-2810
[2]   Imidazole- and imidazolium-containing polymers for biology and material science applications [J].
Anderson, Emily B. ;
Long, Timothy E. .
POLYMER, 2010, 51 (12) :2447-2454
[3]   Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge. [J].
Arias, Cesar A. ;
Murray, Barbara E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05) :439-443
[4]   ANTIBACTERIAL PEPTIDES - KEY COMPONENTS NEEDED IN IMMUNITY [J].
BOMAN, HG .
CELL, 1991, 65 (02) :205-207
[5]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[6]   Antibiofilm activities of 1-alkyl-3-methylimidazolium chloride ionic liquids [J].
Carson, Louise ;
Chau, Peter K. W. ;
Earle, Martyn J. ;
Gilea, Manuela A. ;
Gilmore, Brendan F. ;
Gorman, Sean P. ;
McCann, Maureen T. ;
Seddon, Kenneth R. .
GREEN CHEMISTRY, 2009, 11 (04) :492-497
[7]   Design, Synthesis, and Biological Evaluation of β-Lactam Antibiotic-Based Imidazolium- and Pyridinium-Type Ionic Liquids [J].
Cole, Marsha R. ;
Li, Min ;
El-Zahab, Bilal ;
Janes, Marlene E. ;
Hayes, Daniel ;
Warner, Isiah M. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (01) :33-41
[8]   Self-aggregation and antimicrobial activity of imidazolium and pyridinium based ionic liquids in aqueous solution [J].
Cornellas, Anna ;
Perez, Lourdes ;
Comelles, Francesc ;
Ribosa, Isabel ;
Manresa, Angeles ;
Teresa Garcia, M. .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2011, 355 (01) :164-171
[9]   Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts [J].
Demberelnyamba, D ;
Kim, KS ;
Choi, SJ ;
Park, SY ;
Lee, H ;
Kim, CJ ;
Yoo, ID .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) :853-857
[10]   SCANNING ELECTRON-MICROSCOPY OF CANDIDA-ALBICANS AFTER INVITRO TREATMENT WITH MICONAZOLE [J].
DENOLLIN, S ;
BORGERS, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 7 (05) :704-711